Interested in volunteering for a clinical trial?

Clinical Trials

With many spinal cord clinical trials already underway in the U.S. and more to come over the next few years, there is an urgent need to build bridges among researchers and pave the way for accelerated progress. People who volunteer and participate in these studies are a critical part of the recent momentum.

While it’s certainly exciting to see promising research advance to human trials, it is important to understand how clinical studies are conducted and what is expected of participants prior to signing up. To ensure you are prepared to volunteer as a research candidate, please review the below guidelines and information from the Reeve Foundation and our partners.

First step: Do your homework

The first step is to empower yourself with information about the field of spinal cord research. Get to know its origins and dive into the advancements being made today. The Reeve Foundation offers a wealth of literature on the evolution of spinal cord research as well as recent discoveries in the field.

In today's wired world, there is a tremendous amount of information available about treatments, proven and unproven, for paralysis and other complications of a spinal cord injury. As a result, it is challenging to separate the wheat from the chaff.

The Christopher & Dana Reeve Foundation was one of the founding members of the International Campaign for Cures of Spinal Cord Injury Paralysis (ICCP). We, along with our ICCP colleagues, believe the ICCP Guide for Experimental Treatments for Spinal Cord Injury is a crucial resource for people living with spinal cord injury, their families and their caregivers.

We hope that readers will use the ICCP guide, and other resources provided below, to think critically about potential therapies for spinal cord injury and pose the questions that should be asked.

Understanding the clinical trial process

Clinical trials often compare a new product or therapy with another that already exists to determine if the new one is as successful or better than the existing one. In some studies, participants may be assigned to receive a placebo (an inactive product that resembles the test product, but without its treatment value).

Comparing a new product with a placebo can be the fastest and most reliable way to demonstrate the new product's therapeutic effectiveness. However, placebos are not used if a person would be put at risk by not having effective therapy. Potential participants are told if placebos will be used in the study before they enter a trial.

Randomization is the process by which two or more alternative treatments are assigned to volunteers by chance rather than by choice. This is done to avoid any bias with researchers assigning volunteers to one group or another. The results of each treatment are compared at specific points during a trial.

In single or double-blind studies, participants do not know which medicine is being used, so they can describe what happens without bias. "Blind" studies prevent members of the research team or study participants from influencing the results. This allows scientifically accurate conclusions.

In single-blind studies, only the participant is not told what is being administered. In a double-blind study, neither participant nor members of the research team are not told who is getting which medication. This is so their observations will not be biased.

Before joining a clinical trial, a participant must qualify for the study. All clinical trials have inclusion/exclusion criteria, based on factors such as age, gender, the type and stage of a disease/injury, previous treatment history, and other medical conditions.

Weighing the risk: Pros and cons of joining a study

Clinical trials involve risks, just as routine medical care and the activities of daily living. When weighing the risks of research, consider two important factors:

  • the degree of harm that could result from participating in the study, and
  • the chance of any harm occurring

Potential benefits
Well-designed and well-executed clinical trials provide the best approach for participants to:

  • Play an active role in their healthcare
  • Gain access to new research treatments before they are widely available
  • Receive regular and careful medical attention from a research team that includes doctors and other health professionals
  • Help others by contributing to medical research
  • It is possible also that the tested treatment is effective and enhances quality of life

Potential risks
The specific risks associated with a research protocol are described in detail in the informed consent document, which participants are asked to sign before participating in research. Risks to participating in clinical trials include the following:

  • There may be unpleasant, serious, or even life-threatening side effects to experimental treatment
  • The study may require more time and attention than standard treatment would, including visits to the study site, more tests, more treatments, hospital stays, or complex dosage requirements

What questions should I ask if I am selected to participate in a clinical trial?

The National Institutes of Health suggest that if you are offered a clinical trial, ask questions or bring up any issues concerning the trial at any time. Asking questions will arm you with information to feel confident and informed so that you are prepared for your role as a participant.

The following suggestions may give you some ideas as you think about your own questions.

The study

  • What is the purpose of the study?
  • Why do researchers think their approach may be effective?
  • Who is funding the study?
  • Who has reviewed and approved the study?
  • How are study results and safety of participants being checked?
  • How long will the study last?
  • What will my responsibilities be if I participate?

Possible risks and benefits

  • What are my possible short-term benefits?
  • What are my possible long-term benefits?
  • What are my short-term risks, such as side effects?
  • What are my possible long-term risks?

Participation and care

  • What kinds of therapies, procedures and/or tests will I undergo during the trial?
  • Will they hurt, and if so, for how long?
  • How do the tests in the study compare with those I would have outside of the trial?
  • Will I be able to take my regular medications while in the clinical trial?
  • Where will I have my medical care?
  • Who will be in charge of my care?

Personal issues

  • How could being in this study affect my daily life?
  • Can I talk to other people in the study?

Tips for asking your doctor about trials

  • Consider taking a family member or friend along, for support and for help in asking questions or recording answers
  • Plan ahead what to ask – but don't hesitate to ask any new questions you think of while you're there
  • Write down your questions in advance
  • Write down the answers, so you can review
  • Ask about bringing a tape recorder (even if you write down answers)

Helpful resources and guidelines on clinical trials

The goal of is to allow individuals with spinal cord injury (SCI), their families and health care professionals to get common language information about clinical trials as developed by experienced clinical investigators (we call these curations or curated trials). We have started by curating trials looking for participants for studies of interventions targeting improvement of neurological and related functional outcomes, currently underway in North America, Europe and Australia.

You can also visit for a complete list of all trials, searchable by condition, locale, sponsor, etc.

Remember that becoming educated on the clinical trial process does not commit you to anything, but it will prepare you for when you are ready to volunteer.